课题基金 / 基金详情

TRANSGENIC ANIMAL MODELS OF HUMAN INHERITED DISORDERS

TRANSGENIC ANIMAL MODELS OF HUMAN INHERITED DISORDERS
人类遗传性疾病的转基因动物模型
批准号:
6162911
负责人:
E I GINNS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

E I GINNS的其他基金

相关文献

中文摘要
翻译
在许多情况下,自然发生的动物模型的人类遗传
英文摘要
In many cases naturally occurring animal models of human inherited disorders, especially those affecting the nervous system, have not been described. In those cases where the gene defect has been identified, the introduction of mutations into the germ line of mice can provide a unique opportunity to generate mice having appropriate phenotypes where disease pathogenesis and treatment can be studied. Transgenic mice are generated by both pronuclear microinjection of DNA into fertilized eggs and by gene targeting by introduction of genetically modified murine embryonic stem cells into blastocyst stage mouse embryos. In addition to the generation of "null allele" or "knockout" mice, other techniques are being developed for the introduction of subtle mutations into the germline of mice. Transgenic mice with genes under the control of cell(including glia and neuronal) or tissue specific inducible/repressible promoters are also under study, particularly with respect to gene expression in the nervous system. Murine models of inherited disorders affecting the nervous system are being produced using these techniques, and the developmental and tissue specific expression of genes is characterized in these transgenic mice. Our collaborative efforts to generate transgenic mouse models of human disorders are providing valuable tools extending our understanding of disorders affecting the nervous system and for the evaluation of new treatments, including protein/enzyme replacement, cellular transplantation, and gene transfer therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR GENETICS OF LYSOSOMAL DISORDERS
MOLECULAR GENETIC STUDIES OF THE MUCOPOLYSACCHARIDOSES
GENE REGULATION WITHIN THE NERVOUS SYSTEM
STUDIES OF GAUCHER DISEASE AND OTHER NEUROGENETIC DISORDERS TOWARD GENE THERAPY